Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial intelligence and machine learning in cancer imaging
285
Zitationen
15
Autoren
2022
Jahr
Abstract
An increasing array of tools is being developed using artificial intelligence (AI) and machine learning (ML) for cancer imaging. The development of an optimal tool requires multidisciplinary engagement to ensure that the appropriate use case is met, as well as to undertake robust development and testing prior to its adoption into healthcare systems. This multidisciplinary review highlights key developments in the field. We discuss the challenges and opportunities of AI and ML in cancer imaging; considerations for the development of algorithms into tools that can be widely used and disseminated; and the development of the ecosystem needed to promote growth of AI and ML in cancer imaging.
Ähnliche Arbeiten
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 · 28.787 Zit.
TNM Classification of Malignant Tumours
1987 · 16.123 Zit.
A survey on deep learning in medical image analysis
2017 · 13.485 Zit.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.734 Zit.
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
2010 · 9.099 Zit.
Autoren
Institutionen
- Royal Marsden Hospital(GB)
- Champalimaud Foundation(PT)
- Charité - Universitätsmedizin Berlin(DE)
- University College London(GB)
- University of Pennsylvania(US)
- Boston University(US)
- Massachusetts General Hospital(US)
- Harvard University(US)
- Hospital Universitari i Politècnic La Fe(ES)
- Birkbeck, University of London(GB)
- Virginia Tech(US)
- Stanford University(US)
- Imperial College Healthcare NHS Trust(GB)
- University of Cambridge(GB)
- University of Arkansas for Medical Sciences(US)